| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT06973109 Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes |
overall status: "Not Yet Recruiting" → "Withdrawn" |
| 2026-06-05 | NCT06973109 Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes |
critical why stopped: null → "Investigator left the institution" |
| 2026-06-05 | NCT06973109 Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes |
Enrollment reduced: 36 -> 0 participants |
| 2026-06-05 | NCT06973109 Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes |
Sponsor changed: Nitin Agarwal -> University of Pittsburgh |
| 2026-05-28 | NCT05972551 Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in… |
overall status: "Recruiting" → "Active Not Recruiting" |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06558188 | Combined Anabolic Therapy | Osteoporosis, Postmenopausal | Recruiting |
| NCT05058976 | Romosozumab Use to Build Skeletal Integrity | Osteoporosis | Active, Not Recruiting |
| NCT05010590 | Anabolic Therapy in Postmenopausal Osteoporosis | Postmenopausal Osteoporosis | Active, Not Recruiting |
| Phase 3 | |||
| NCT06533865 | Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic… | FHA (Functional Hypothalamic Amenorrhea) | Recruiting |
| NCT05972551 | Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in… | Osteogenesis Imperfecta | Active, Not Recruiting |
| Phase 2 | |||
| NCT04800367 | Romosozumab/Denosumab Study for Premenopausal IOP | Premenopausal Idiopathic Osteoporosis | Active, Not Recruiting |
| NCT04232657 | Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI | Spinal Cord Injury (=3 Years) | Active, Not Recruiting |
| Phase 1 | |||
| NCT07384104 | Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and… | Osteoporosis | Enrolling by Invitation |